An observational study in Total Hip Resurfacing, sponsored by Zimmer Biomet. Completed at 6 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-02-23.
Sponsored by Zimmer Biomet · Observational
Observational study on ReCap/Magnum in Total Hip Replacement and Resurfacing.
This observational study intends to collect efficacy and safety data on ReCap/Magnum in Total Hip Replacement and Resurfacing.
Zimmer Biomet is the lead sponsor of 271 studies on the registry; 28 are open to participants now.
Of its 23 completed or terminated interventional studies of FDA-regulated products, 19 (83%) have results posted.
Counted across the registry records on this site, refreshed daily.
Consecutive series of patients received Total Hip Replacement or Resurfacing with ReCap/Magnum for Their Respective Indications for Use/Intended Uses
Inclusion Criteria:
Consecutive series of patients received Total Hip Replacement or Resurfacing with ReCap/Magnum for Its Respective Indications for Use/Intended Uses
Consecutive series of patients received Total Hip Resurfacing with ReCap/Magnum
Consecutive series of patients received Total Hip Replacement with ReCap/Magnum
Postel-Merle d'Aubigné (PMA), Harris Hip Score
Time frame: 1yr and 2yr
Complication
Time frame: Any time
Survival
Time frame: 1yr and 2yr
This study is completed, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zimmer Biomet